Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001089294-10-000003
Filing Date
2010-11-03
Accepted
2010-11-03 11:58:54
Documents
1
Effectiveness Date
2010-11-03
Items
Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 5526
  Complete submission text file 0001089294-10-000003.txt   7105
Mailing Address 900 THIRD AVENUE 14TH FLOOR NEW YORK NY 10022
Business Address 900 THIRD AVENUE 14TH FLOOR NEW YORK NY 10022 (212) 446-5362
PHARMACEUTICAL OPPORTUNITIES FUND L P (Filer) CIK: 0001089294 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-149946 | Film No.: 101160526